COMMUNIQUÉS West-GlobeNewswire

Chembio Reports Preliminary Third Quarter 2018 Revenue
22/10/2018
Signs Definitive Agreement to Acquire opTricon GmbH MEDFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio” or the “Company”), a leading point-of-care diagnostics company [...]
Osmotica Pharmaceuticals plc Announces Closing of Initial Public Offering
22/10/2018
BRIDGEWATER, N.J., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the closing of its initial public offering of 7,647,500 ordinary shares at [...]
CLEARSIDE, XIPERE™ and PEACHTREE to be Front and Center at AAO 2018
22/10/2018
ALPHARETTA, Ga., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Harvard Bioscience Names Kam Unninayar as Chief Financial Officer
22/10/2018
Seasoned Financial Executive With More Than a Decade in Global Life Science Instrumentation, Will Begin on November 26 HOLLISTON, Mass., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “ [...]
Akcea Therapeutics to Hold Third Quarter 2018 Financial Results Webcast
22/10/2018
Webcast scheduled for Monday, November 5 th at 4:30 p.m. Eastern Time BOSTON, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today that [...]
Aclaris Announces Closing of Public Offering of Common Stock
22/10/2018
WAYNE, Pa., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Evolus Expands Leadership Team with Appointments of Key Executives
22/10/2018
Appoints Kurt Knab as Vice President, Sales Appoints Alejandro “Alex” Sabad as Vice President, Operations Appoints Amy Marinne Fox as Vice President, Human Resources IRVINE, Calif., Oct. 22, 2018 (GLOBE NEWSWIRE) -- [...]
Ovid Therapeutics Receives “Company Making a Difference Award” from CDKL5 Deficiency Disorder Community
22/10/2018
NEW YORK, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
BIOPHYTIS : Interim Results 2018 and Perspective on Activity
22/10/2018
PARIS, Oct. 22, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris: ALBPS), a biotechnology company specializing in the development of drug candidates to fight age-related degenerative diseases, announces the [...]
Marrone Bio Innovations Pest Management Products Win the International Biocontrol Manufacturers Association’s Bernard Blum Award for a Novel Biocontrol Solution
22/10/2018
DAVIS, Calif., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that the [...]
Scientus Pharma Obtains Health Canada Approval for Cannabis Oils and Softgel Production
22/10/2018
TORONTO, Oct. 22, 2018 (GLOBE NEWSWIRE) -- HydRx Farms Ltd. (o/a Scientus Pharma) (“Scientus” or the “Company”), a biopharmaceutical company conducting research and product development for extracts and formulations [...]
POSITIVE TRIAL RESULTS WITH FILGOTINIB IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS BOTH PUBLISHED IN THE LANCET
22/10/2018
Phase 2 EQUATOR Data Demonstrating Efficacy in Psoriatic Arthritis Also Presented in a Plenary Session at 2018 ACR/ARHP Annual Meeting Chicago, October 22, 2018; 19.15 CET - Gilead Sciences, Inc. (Nasdaq: GILD) and [...]
CROSSJECT : Renforcement de Gemmes Venture au capital de Crossject par conversion d'obligations convertibles
22/10/2018
Communiqué de Presse Renforcement de GEMMES VENTURE au capital de CROSSJECT par conversion d'obligations convertibles Dijon, le 22 Octobre 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Tabula Rasa HealthCare Participates in 2018 National PACE Association Conference
22/10/2018
Hosts Portland Uncorked! Introduces New Company Division and Sponsors Leadership Awards Luncheon MOORESTOWN, N.J., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a healthcare [...]
AB Science announces that the masitinib phase 3 study in Alzheimer's disease has completed patient recruitment
22/10/2018
Paris, October 22 2018, 6pm The masitinib phase 3 study in Alzheimer's disease has completed patient recruitment Final results will be available in 2019 AB Science SA (NYSE Euronext - FR0010557264 - AB), a [...]
AB Science avoir complété le recrutement de l'étude de phase 3 du masitinib dans le traitement de la maladie d'Alzheimer
22/10/2018
Paris, 22 octobre 2018, 18h AB Science annonce avoir complété le recrutement de l'étude de phase 3 du masitinib dans le traitement de la maladie d'Alzheimer Les résultats finaux seront disponibles en 2019 AB Science SA [...]
Q-Centrix Celebrates Eight Years of Growth and the Quality Contributions of Hospitals and Healthcare Quality Professionals Everywhere During HQW 2018
22/10/2018
Q-Centrix Hospital Partners Have Achieved Millions in Cost-Savings and Significantly Reduced Common Hospital Infections Through Strategic Improvement Efforts Chicago, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Q-Centrix applauds [...]
Sanofi: Disclosure of trading in own shares
22/10/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
22/10/2018
Pièce jointe Reporting FR.pdf

Pages